Jensen Investment Management Inc. Sells 13,270 Shares of Encompass Health Corporation $EHC

Jensen Investment Management Inc. cut its position in shares of Encompass Health Corporation (NYSE:EHC) by 18.7% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 57,560 shares of the company’s stock after selling 13,270 shares during the period. Jensen Investment Management Inc. owned about 0.06% of Encompass Health worth $7,059,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also recently made changes to their positions in EHC. WPG Advisers LLC bought a new stake in shares of Encompass Health in the first quarter valued at about $27,000. Mitsubishi UFJ Asset Management Co. Ltd. raised its holdings in shares of Encompass Health by 749.0% in the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 416 shares of the company’s stock valued at $42,000 after purchasing an additional 367 shares in the last quarter. Parkside Financial Bank & Trust lifted its position in shares of Encompass Health by 179.5% in the 2nd quarter. Parkside Financial Bank & Trust now owns 478 shares of the company’s stock worth $59,000 after purchasing an additional 307 shares during the period. Park Place Capital Corp bought a new position in shares of Encompass Health during the second quarter valued at approximately $72,000. Finally, Caitong International Asset Management Co. Ltd increased its holdings in Encompass Health by 19.0% during the first quarter. Caitong International Asset Management Co. Ltd now owns 720 shares of the company’s stock valued at $73,000 after buying an additional 115 shares during the period. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Analyst Ratings Changes

Several brokerages have issued reports on EHC. Raymond James Financial raised Encompass Health to a “strong-buy” rating in a research report on Friday, October 31st. Bank of America boosted their target price on shares of Encompass Health from $145.00 to $160.00 and gave the stock a “buy” rating in a report on Wednesday, September 10th. UBS Group raised their price target on shares of Encompass Health from $140.00 to $150.00 and gave the company a “buy” rating in a report on Thursday, October 2nd. Zacks Research raised shares of Encompass Health from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, October 21st. Finally, Barclays raised their target price on shares of Encompass Health from $141.00 to $150.00 and gave the company an “overweight” rating in a research note on Thursday, October 30th. Three investment analysts have rated the stock with a Strong Buy rating and eight have issued a Buy rating to the company. Based on data from MarketBeat.com, Encompass Health currently has an average rating of “Buy” and a consensus target price of $142.86.

Insider Buying and Selling at Encompass Health

In related news, EVP Patrick William Tuer sold 1,020 shares of the business’s stock in a transaction on Wednesday, August 27th. The shares were sold at an average price of $123.59, for a total value of $126,061.80. Following the completion of the transaction, the executive vice president directly owned 18,846 shares in the company, valued at $2,329,177.14. The trade was a 5.13% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 2.00% of the stock is currently owned by company insiders.

Encompass Health Stock Performance

Shares of NYSE EHC opened at $113.49 on Friday. The stock has a market cap of $11.42 billion, a price-to-earnings ratio of 21.45, a PEG ratio of 2.20 and a beta of 0.91. Encompass Health Corporation has a 12 month low of $87.85 and a 12 month high of $127.99. The company has a 50 day simple moving average of $122.64 and a two-hundred day simple moving average of $119.69. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.76.

Encompass Health (NYSE:EHC) last posted its earnings results on Wednesday, March 16th. The company reported $0.93 earnings per share (EPS) for the quarter. The company had revenue of $136.30 million during the quarter. Encompass Health had a net margin of 9.33% and a return on equity of 18.19%. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. As a group, analysts predict that Encompass Health Corporation will post 4.8 earnings per share for the current year.

Encompass Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Stockholders of record on Friday, January 2nd will be paid a dividend of $0.19 per share. The ex-dividend date of this dividend is Friday, January 2nd. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.7%. Encompass Health’s dividend payout ratio (DPR) is presently 14.37%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.